A patient has a defective liver FBPase-2 enzyme, the enzyme that converts F2,6P into F6P. This enzyme is inactive. What effect would this have on the differential regulation of glycolysis and gluconeogenesis in liver cells? How would this affect a person’s ability to respond appropriately to a low blood sugar state? What about a high blood sugar state?

A patient has a defective liver FBPase-2 enzyme, the enzyme that converts F2,6P into F6P. This enzyme is inactive. What effect would this have on the differential regulation of glycolysis and gluconeogenesis in liver cells? How would this affect a person’s ability to respond appropriately to a low blood sugar state? What about a high blood sugar state?

Essentials of Pharmacology for Health Professions

7th Edition

ISBN:9781305441620

Author:WOODROW

Publisher:WOODROW

Chapter23: Endocrine System Drugs

Section: Chapter Questions

Problem 15CRQ

See similar textbooks

Similar questions

Figure 37.11 Pancreatic tumors may cause excess secretion of glucagon. Type I diabetes results from the failure of the pancreas to produce insulin. Which of the following statement about these two conditions is true? A pancreatic tumor and type I diabetes will have the opposite effects on blood sugar levels. A pancreatic tumor and type I diabetes will both cause hyperglycemia. A pancreatic tumor and type I diabetes will both cause hypoglycemia. Both pancreatic tumors and type I diabetes result in the inability of cells to take up glucose.
Which of the following statements about the integration of fat and carbohydrate metabolism control is correct? a. High insulin/glucagon ratio activates lipolysis in muscle b. High insulin/glucagon ratio inhibits lipogenesis in liver. c. Low insulin/glucagon ratio activates lipolysis in adipocytes. d. Insulin-dependent glucose transporters are recruited to their functional membrane site when insulin levels are low
An individual has a genetic deficiency that prevents the production of glucokinase. Following a carbohydrate meal, do you expect blood glucose levels to be high, low, or about normal? What organ accumulates glycogen under these circumstances?
In the regulation of gluconeogenesis during fasting, which of the following decreases? a. Release of fatty acid from adipose tissue b. Fatty acid oxidation in the liver c. Blood glucose levels d. AcetylCoA in the liver
when would the concentration of pancreatic amylase in your body be at the highest? when would it be at the lowest? explain your reas
Glucose can be made from oxaloacetate during gluconeogenesis, but if oxaloacetate concentrations are decreased,what other substance can be used to make glucose? How might this contribute to increased fat loss?
Which of the following concerning glucagon is TRUE? a. It is a hormonal protein that uptakes glucose and amino acids from blood. b. Its activity is up-regulated when blood glucose increases. c. It is a hormonal protein that up-regulates glycogenolysis. d. It decreases gluconeogenesis.
As a result of complete fasting for 3 days, a significant change in metabolism occurs. How will the level of fatty acids in the blood change? What hormone causes these changes? Justify your answer schematically.
During the FEED cycle, the two major effects of INSULIN on the liver involves ____. Select one: a. glucose consumption (glycolysis and glycogen synthesis), fatty Acid and TAG synthesis b. glucose release and fatty acid synthesis c. TAG and fatty acid degradation d. gluconeogenesis and glycogenolysis
The Km of liver glucokinase is _____ than typical blood glucose concentrations. At typical blood glucose concentrations, therefore, the rate of glucose catabolism in liver cells is relatively ____. Much higher; fast Much higher; slow Much lower; fast Much lower; slow
Fatty acids appear to stimulate insulin secretion to a much greater extent when glucose is also present. Why is this significant?
According to glycogen metabolism, which of the following statementsis/are not true? I. Insulin results in dephosphorylation and subsequentactivation ofglycogen synthase. II. cAMP is a second messenger that triggers an increase in glycogensynthesis. III. Release of epinephrine leads to increased glycogen breakdown. IV. Glucagon promotes glycogen breakdown. V. Glucose-6-phosphate is an allosteric inhibitor of.phosphorylase A) I and VB) III and VC) II onlyD) III and IVE) V only